ctrl K

Watchlist Price Alert

Acurx Pharmaceuticals Inc... (ACXP)

NASDAQ: ACXP · Real-Time Price · USD

0.35

0.01 (2.64%)

At close: May 07, 2025, 1:51 PM

Acurx Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	3.71M	7.47M	9.11M	12.96M	3.18M	2.48M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a
Receivables	51.13K	129.16K	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	3.86M	7.71M	9.38M	13.25M	3.22M	2.53M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a
Total Assets	3.86M	7.71M	9.38M	13.25M	3.22M	2.53M
Account Payables	n/a	n/a	29.54K	63.37K	n/a	2.3K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	16.63K	n/a
Other Current Liabilities	3.24B	716.31K	n/a	n/a	n/a	454.98K
Total Current Liabilities	3.24B	3.04M	2.06M	843.91K	472.56K	1.71M
Long-Term Debt	n/a	n/a	n/a	n/a	49.88K	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	2.06M	n/a	49.88K	n/a
Total Liabilities	3.24M	3.04M	2.06M	843.91K	522.43K	1.71M
Total Debt	n/a	n/a	n/a	n/a	66.5K	n/a
Common Stock	17.03K	14.47K	11.63K	10.22K	16.5M	10.02M
Retained Earnings	-67.32B	-53.22M	-38.64M	-26.55M	-13.8M	-9.2M
Comprehensive Income	n/a	n/a	-38.64M	-26.55M	-13.8M	-9.2M
Shareholders Equity	615.12M	4.67M	7.32M	12.41M	2.7M	819.85K
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a